Compound ID | 660
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | VRE |
| Institute where first reported: | Morphochem AG (Biovertis, Austria) |
| Year first mentioned: | 2002 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Morphochem AG was taken over in 2006 by Biovertis AG but continued research till 2006 when finances wre prioritised to advanced projects only. |
| External links: | |
| Citation: |